The drug pyridostigmine is an acetylcholinesterase inhibitor that prevents the enzymatic breakdown of acetylcholine in synaptic clefts, including at neuromuscular junctions and parasympathetic post-ganglionic synapses.
Which of the following clinical conditions could this drug be used to treat?
Only 1 and 2
Only 2 and 3
Only 1
1, 2 and 3
22 exam-style questions on OCR A A Level Biology Neuronal communication. Each one has a worked solution and a mark scheme showing where the marks go.